Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, announced U.S. Food and Drug Administration (FDA) approval of an update to the VARIPULSE™ Platform’s irrigation flow rate, reflecting the company’s commitment to the evolution of pulsed field ablation (PFA) innovation following real-world clinical practice. “By learning from real-world experience
LivsMed is leading a revolution in surgical care, making advanced remote robotic surgery both accessible and affordable for hospitals and patients worldwide. With the introduction of STARK™—the company’s first and the world’s newest telesurgery-native robotic system—LivsMed is fundamentally transforming the landscape. Remote robotic surgery now holds the promise of delivering
Human Phenotype Project (HPP), a large-scale, deep-phenotype, prospective longitudinal study encompassing a diverse range of ethnic groups, has announced the publication of its latest groundbreaking findings in Nature Medicine. This landmark research, led by scientists from the Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) in collaboration with global partners,
FUJIFILM Healthcare Americas Corporation, a leader in medical imaging and informatics, has announced the introduction of advanced automation features for its FDR Visionary Suite digital radiography room. Designed to streamline high-volume imaging in hospital radiology departments and imaging centers, these new capabilities aim to boost workflow efficiency and elevate both
Burjeel Holdings, a leading super-specialty healthcare services provider in MENA listed on the Abu Dhabi Securities Exchange, has announced the acquisition of a 100% stake in Riyadh’s PhysioTrio Physiotherapy Center through its subsidiary, Burjeel Arabia. This strategic move reinforces Burjeel’s commitment to expanding its presence in Saudi Arabia and advancing
Hupe, a premier provider of personalized wellness programs, proudly announces it has been officially accredited by the Care Quality Commission (CQC), the UK’s independent regulator for health and social care services. This achievement highlights Hupe’s dedication to upholding the highest standards of clinical governance, safety, and medically-led care within the
M42, a global leader in health driven by technology, AI, and genomics, is partnering with GE HealthCare, a worldwide innovator in medical technology, pharmaceutical diagnostics, and cloud-first AI-powered digital solutions, to advance diagnostic accuracy and deliver more personalized patient outcomes — a major stride toward the future of smart healthcare
Marking a major step in expanding access to advanced cell and gene therapies for children in the UAE, the Department of Health – Abu Dhabi (DoH), the Emirate’s healthcare regulator, has signed a strategic MoU with Children’s National Hospital, a leading pediatric institution in Washington, D.C. The collaboration will establish
Sheikh Shakhbout Medical City (SSMC), a flagship hospital in the UAE for serious and complex care and a subsidiary of the PureHealth group, has announced its collaboration with global biopharmaceutical company AstraZeneca, to launch the ‘Pure Air Solution’ (PAS) initiative. This partnership, formalized through a Memorandum of Understanding (MoU), focuses
Eli Lilly and Company has announced detailed results from QWINT-1, QWINT-3, and QWINT-4 Phase 3 clinical trials evaluating the safety and efficacy of investigational once-weekly insulin efsitora alfa (efsitora) in adults with type 2 diabetes who used insulin for the first time, previously used daily basal insulin, and previously used daily
Get notified about new articles
